352 results on '"A Roux"'
Search Results
2. Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database
3. Evaluation of the prevalence of new-onset musculoskeletal symptoms in patients hospitalized for severe SARS-CoV-2 infection during the first two COVID waves in France: A descriptive analysis of the clinical data warehouse of 39 hospitals in France
4. Management of bone fragility in patients with rheumatoid arthritis in France: An analysis of a national health insurance claims database
5. Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases
6. Impact of smoking on femorotibial and hip osteoarthritis progression: 3-year follow-up data from the KHOALA cohort
7. Pregnancy rates and outcomes in early axial spondyloarthritis: An analysis of the DESIR cohort
8. Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis
9. Absence of association between inflammatory dietary pattern and low trauma fractures: Results of the French cohort NutriNet-Santé
10. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020
11. Baseline MRI inflammation is not a determinant of 5-year bone mineral density loss in patients with early spondyloarthritis
12. Biological secondary contributors to osteoporosis in fractured patients, is an early systematic assay relevant?
13. Ultrasonographic criteria for the diagnosis of erosive rheumatoid arthritis using osteoarthritic patients as controls compared to validated radiographic criteria
14. 2018 update of French recommendations on the management of postmenopausal osteoporosis
15. Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves
16. Current role for bone absorptiometry
17. Association between hip morphology and prevalence, clinical severity and progression of hip osteoarthritis over 3 years: The knee and hip osteoarthritis long-term assessment cohort results
18. Femoro-tibial knee osteoarthritis: One or two X-rays? Results from a population-based study
19. Trabecular Bone Score: Where are we now?
20. Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort
21. Ultrasound study of entheses in psoriasis patients with or without musculoskeletal symptoms: A prospective study
22. The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis
23. 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis
24. Validation of the French version of the Compliance Questionnaire for Rheumatology (CQR-5), a self-reporting questionnaire specific to patients with chronic inflammatory rheumatic disease
25. Usefulness of bone density measurement in fallers
26. Difficulties in the diagnosis of vertebral fracture in men: Agreement between doctors
27. Long-term systemic glucocorticoid therapy: Patients’ representations, prescribers’ perceptions, and treatment adherence
28. Prospective assessment of bone texture parameters at the hand in rheumatoid arthritis
29. Real frequency of ordinary and atypical sub-trochanteric and diaphyseal fractures in France based on X-rays and medical file analysis
30. Blockade of intra-articular TNF in peripheral spondyloarthritis: Its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers
31. Opportunistic screening for osteoporosis
32. Reproducibility of radiographic hip measurements in adults
33. Cost-effectiveness of osteoporosis treatments in postmenopausal women using FRAX™ thresholds for decision
34. The KHOALA cohort of knee and hip osteoarthritis in France
35. Monitoring of bone turnover markers does not improve persistence with ibandronate treatment
36. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis
37. Management of glucocorticoid-induced osteoporosis: Lessons for clinical practice
38. Are glucocortoids really deleterious to bone health?
39. Management of male osteoporosis: lessons for clinical practice
40. Oxytocin and bone remodelling: Relationships with neuropituitary hormones, bone status and body composition
41. The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: Study design and baseline characteristics of the 708 recruited patients
42. Decrease of inpatient mortality for hip fracture in France
43. Severe osteoporosis: diagnosis and follow-up. Lessons for clinical practice
44. Severe osteoporosis: does structural monitoring help?
45. Osteoporosis and mortality
46. New treatment targets in osteoporosis
47. Calcium intake and the risk of osteoporosis and fractures in French women
48. Sudden skin necrosis over bilateral scapula regions revealing giant cell arteritis
49. Effect of discontinuing TNFα antagonist therapy in patients with remission of rheumatoid arthritis
50. Prevalence and features of osteoporosis in the French general population: The Instant study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.